Shares of regenerative medicine stem cell companies are reacting to visibility and sentiment issues as stocks are acting as a thermometer of investor emotion. Read more…
Shares of regenerative medicine stem cell companies are suffering from the summer doldrums and lack of attention Read more…
Shares of regenerative medicine stem cell companies have been laggard during negative market gyrations Read more…
Shares of regenerative medicine stem cell companies have mediocre volume but stealth upward movement during negative market gyrations Read more…
Shares of regenerative medicine stem cell companies have been subject to continuous market gyrations. Read more…
Shares of regenerative medicine stem cell companies were UP from unheraled LOWS due to macro issues and negative market gyrations. Read more…
Shares of regenerative medicine stem cell companies have been relatively EVEN although down due to macro issues and negative market gyrations. Read more…
Shares of regenerative medicine stem cell companies were AGAIN off due to macro issues and negative market gyrations. Read more…
Shares of regenerative medicine stem cell companies were off due to macro issues and negative government data. Read more…
Shares of regenerative medicine stem cell companies were off due to lack of attention of a holiday weekend by Friday, 5/27/11. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.